Introduction (A-J Valleron and J Bignon)
policies and are trying to establish a common position. Many questions remain unanswered, however, such as: are the present regulatory industrial thresholds (for example, in France 0 5 fibre/ml of chrysotile) low enough? What does low enough mean? Is it the level below which there is no risk?
What about the risks of non-occupational exposure to asbestos? What is the rationale for remedy or removal of sprayed asbestos in buildings with asbestos containing materials? What future risks are possibly associated with new fibrous materials that could replace asbestos? How do we guarantee that efficient alarm systems are now available to avoid putting or keeping on the market products that may also be dangerous? What epidemiological surveys should be organised on which to base a rational approach? The answers (ifany) to these questions can be extrapolated to other carcinogenic hazards, either chemical or physical. Whatever the environmental carcinogen under consideration, the difficulties lie in assessing the risk for very low doses, setting a maximum exposure threshold, and finding good surveillance systems. The conflicts between persons, groups, and interests are also the same. It was therefore extremely interesting to discuss in depth the case of mineral fibres, where so much expertise has been obtained, and see what can be extrapolated to the epidemiology of other hazards.
Therefore the aims of the symposium reported here were firstly to provide an update on the risks of cancers associated with low dose exposure to mineral fibres, secondly to outline the most suitable methodological tools in the field of environmental epidemiology for risk of cancer associated with exposure to low repeated concentrations of carcinogens. This workshop was limited in size to guarantee true discussions between scientists from 13 European countries, north and south America, Japan, and Africa. M Tubiana opened the meeting with a keynote address on the general problem of epidemiology and decision making associated with low dose exposures (see editorial in this issue of the journal). The meeting was organised around seven themes with suitably long discussion times, to each of which was allocated a moderator to report on the consensus or lack of it. All the documents that the moderators considered important for discussion were previously circulated. The themes and moderators were: Doseeffect relationships at low exposure (J Hughes), interest oflaboratory approachesfor evaluating the effects oflow doses (T W Hesterberg), measurement of dose (T Schneider, G Burdett), rational approachesfor determining exposure standards (P Brochard), identification and assessment of co-factors (J Bignon) , methodology neededfor collaborative epidemiology (D Hemon), and tools for pooling data and for pooling knowledge (A-J Valleron). Also, a single session was devoted to a presentation of 10 ongoing studies in Europe (M Albin, Lund (Sweden); J Ameille, Paris (France); Y I Baris, Ankara (Turkey); K Injection of fibres into animal cavities bypasses all respiratory defence mechanisms of the lung and could produce excessive or overload doses in the target tissue. When fibres are injected into the pleura or peritoneum of an animal, not only is the natural pathway of the respiratory tract bypassed, thus eliminating innate anatomical fate and any potential for normal clearance, but the concomitant leaching, degradation, fragmentation, or other transformations are unlikely to be the same as after inhalation. The pathogenicity offibres is known to be influenced by some of these transformations. Thus fibres injected into the pleura or peritoneum may be qualitatively and quantitatively different from fibres that have been inhaled and translocated to the target issue. These weaknesses of intracavity injection studies severely limit their relevance for quantitative human risk assessment. '2 Inhalation is the only route of exposure to fibres that has been associated with disease in humans. Thus animal inhalation models are the most relevant for assessing the potential carcinogenic risk of fibres to humans. The animal model must be capable of reproducing the asbestos related lung diseases observed in humans, including fibrosis, lung cancer, and mesothelioma.
A chronic inhalation study in animals should include adequate exposure of the target tissues and animals should be monitored for tumour formation throughout their lifetime or until 20% survival occurs. The dimensions of the fibres used in these studies should allow deposition into the deep lung regions, which are the primary target for lung toxicity. Therefore, it is important that fibres used are preselected for their size and that the aerosol generation equipment does not alter this, or increase the non-fibrous particulate fraction. At least three exposure concentrations should be used to determine the dose-response relation of any changes induced and also to determine the no effect level. The effects of the lower concentrations in animal lungs can provide information on the potential effects of low dose fibre exposure in humans.
A number of chronic inhalation studies have been conducted using man made fibres and several more are in progress. The results of these studies vary, depending on protocol and fibre type, but they have provided a very useful insight into the factors that may be important in assessing the potential for adverse effects. For example, the durability of MMMFs within the lung seems to be one of the critical determinants of their chronic toxicity and tumorigenicity. Extremely durable fibres such as refractory ceramic fibres are tumorigenic after chronic animal inhalation.'3'4 Less durable fibres, such as fibrous glass, have not been shown to be tumorigenic after chronic inhalation. '2 Measurement of dose (T Schneider, G Burdett) Two state of the art papers were presented. These were lung fibre analysis as an internal dose marker of low level exposure by B Case and critical review of the results and methodologies for evaluating mineral and man made fibres in buildings by G Burdett.
EXPOSURE AND DOSE
Exposure can be defined as the presence of a potentially noxious substance available for interaction with host, whereas dose is the total integrated amount of exposure that is received by the host.
Exposure to airborne fibres can be characterised quantitatively by the use of time-concentration profiles, where the time integral of the concentration J t2 C:(t)dt is referred to as cumulative exposure or dose for the defined period of time (t,, t2). The duration of the sampling period is often a limitation in that personal samples are rarely run for more than four or eight hour periods and static samples may run for one to five days. This limits the possibility of detecting periods of high and low exposure which may have a seasonal or maintenance cycle.
The concentration of fibres in lung tissue is often referred to as lung burden. This is not considered to be a reliable measure ofdose as there are differences in tissue fibre concentrations between lung lobes, lung parenchyma, subpleural and parenchymal areas, and even between immediately adjacent sites. Also, fibres are cleared, redistributed, and also possibly dissolved at varying rates so that the measured tissue burden does not represent a time integral ofall (2) Exposure assessment can be based on algorithms for ranking past exposure on an absolute scale from plant area job specific information; statistical models with the fit used for extrapolation of incomplete exposure measurements; and deterministic models, which include the physics of dust generation and exposure.
All these methods are promising and should be further developed. A view was expressed that a job exposure matrix approach would not work for low exposed cohorts.
(3) Lung tissues from necropsies. Lung tissue analysis'7 is affected by many methodological and technical aspects. Some improvements were proposed including: reference levels against which to judge a possible exposure should be established by the same laboratory using the same method. This notion implies that no generally applicable background lung burdens can be established at present; interlaboratory comparisons to establish background tissue levels, which do not exist at present; more uniform reporting of the many fibres other than asbestos (rutile, diatoms, aluminium silicates, gypsum) which account for about half of the lung burden in the general population. Population based necropsy studies are feasible and deserve consideration in countries having compulsory autopsy.
MICROSCOPY MEASUREMENTS
Whereas the comparatively large fibre diameter and the isotropic nature of common MMMFs (for example, glass wool, rock wool, and slag wool) allow evaluation by optical microscopy, asbestos and other mineral fibres in the non-occupational environment must be evaluated by analytical electron microscopy. Analytical transmission electron microscopy (ATEM) can be used to reliably identify and size the smallest mineral fibres. Analytical scanning electron microscopy (ASEM) can be used to count and obtain some identification, based on chemistry, of fibres visible by phase contrast optical microscopy, but has serious limitations for analysing fine fibres or those with low atomic weight elements such as sodium. '8 The data available for background airborne asbestos and MMMF exposures in buildings3 suggests that in terms of fibres > 5 pm long, analytical sensitivities for individual samples of the order of 0 0001 to 0 00001 f/ml are required to attempt statistically meaningful estimates of occupant exposures. Due to the presence of non-asbestos materials most electron microscopical methods cannot exceed loadings of41/ mm2 of exposed filter area requiring that at least 2-5 mm2 of filter area be examined to achieve an analytical sensitivity of 0-0001 f/ml. This amount of effort, although possible, is expensive and the use of multiple samples to better characterise the building, which, when combined, give the target analytical sensitivity, is the preferred sampling strategy.
CONCENTRATIONS OF FIBRES IN BUILDINGS
Average airborne concentrations of fibres > 5 pm long in the occupied spaces of buildings without significant damage are of the order of 0 0001 f/ml for MMMF and asbestos. Personal exposures will be significantly higher for maintenance workers who regularly disturb asbestos materials. In the quite exceptional case of asbestos, as in that of ionising radiations, available data provided models for related cancer. For lung cancer, Hughes and Weill27 used the relation O-E = E(b/100)x, where 0 is the number of cancers observed, E the cancers expected, b the variable slope in function of the cohort studied, and x the cumulative dose in f/ml x year. For mesothelioma they derived the equation:
, where I is the incidence, c the average concentration in f/ml, t the latency in relation to the start of exposure, d the duration of exposure and K a variable coefficient depending on the cohort, from the equation initially proposed by Peto et al. 21 Despite the fact that coefficients b and K vary according to the industrial process and therefore the fibre type, the results ofthe computed risk assessment fit reasonably with the available data concerning occupationally exposed workers.27 These models may overestimate the values at low doses by ignoring the notion of "effective threshold" proposed by Browne2930 and illustrated by the increase in the latent period over the expected life span when reducing the dose. All major United States regulation agencies have adopted this methodology as a policy choice for making decisions on the consequences to public health of potential carcinogenic agents. They have, however, made a series of conservative assumptions (the worst-case plausible path of risk estimation), which can grossly overestimate health risk. This has been the object of passionate debates between the conservative protection of public health point of view and the realistic point of view taking into account the social and economic consequences of overly stringent and costly regulation. 3 A second group of facilitating factors might be non-fibrous particles that are usually associated with fibres. Indeed, it has recently been shown in animal inhalation studies that such non-fibrous dusts increased the carcinogenic potential of fibres,'3 this putative factor has not been sufficiently assessed in animal or in human studies. The mechanisms involved in this synergistic effect are not known, but might be related to an overloading of the lung clearance systems. Also, other factors such as diet, particularly vegetable consumption, may be important, but to date have not been sufficiently investigated.37
The host factors relate to the genetic or immunological susceptibility, neither aspect having been sufficiently explored. In future, we should focus on (1) family clusters of mesothelioma and childhood mesothelioma, (2) immunological responses at the alveolar and pleural levels before and during the initiation of lung cancer and mesothelioma to assess the effect of different doses and fibre types.
Methodology needed for collaborative epidemiology (D Hkmon) Three state of the art papers were presented. These were objective exposure assessment by T Schneider, reconstitution ofpast exposures by B Fallentin, and the French experience ofa mesothelioma register and review of other European experiences by P Brochard.
Epidemiology has been successful in describing exposure-response relations in identifying sources of variability of occurrence of disease and in detecting hazardous environmental conditions that can be the target of preventive actions.839 This has led to a number of specific and basic requirements some of which are listed:
The outcome ofconcern should be precisely defined at several levels-namely, asbestos related diseases, lung fibrosis, lung cancer, or mesothelioma; intermediate effect (for example, fibrogenesis) reflecting high exposure and/or predicting more severe disease occurrence (pleural plaques); and direct exposure related effects (for example asbestos lung burden).
The exposure of concern should also be precisely defined-namely, type (type of asbestos fibre, distribution of lengths and diameters); level (in the environment and/or target organ); and duration (and age at exposure, time distribution, latency, age at risk).
The base population to which results seen in a sample can be generalised may be occupationally or geographically defined, and restricted (or not) to that considered to be at high risk because of age, sex, lifestyle and/or other environmental or constitutional conditions.
The choice of study design (cohort, case-control, cross sectional, case control within cohort) has strong consequences on the exposure-outcome associations that can be investigated with precision and power, the biases that can be controlled, and the type and quality of information that can be gathered.
Selection The power of a study has also proved to be a major problem particularly concerning the interpretation of negative results.
Statistical analysis of data has also shown the great increase in power that results from the detailed definition and quantification of exposure and other parameters of interest.
"Weak associations epidemiology" is concerned with the problem of detecting and describing effects that in magnitude may be within the margin of variations of biases and random fluctuations. Thus the epidemiological community of scientists must identify and study problems that can be considered by epidemiological methods; (direct epidemiological evaluation of some exposure-risk associations, identification and validation of early lesions that are predictive of higher future risks, identification of particular segments of the population that are at higher risk to a given exposure, analysis of disease heterogeneity). This can only be achieved by active collaboration between investigators from a wide range of specialties.
Tools for pooling data and for pooling knowledge (A-J Valleron) Two state of the art papers were presented. These were meta-analysis in epidemiology by D Costagliola and the Delphi methods by M Guiguet.
The number of subjects necessary to evaluate the potential risks of cancer associated with low exposures is so large that it can seldom be attained in any single study. Let us take the extreme example of the epidemiology of lung cancer associated with environmental low doses, Hughes and Weill"7 have group.bmj.com on June 20, 2017 -Published by http://oem.bmj.com/ Downloaded from estimated the number of lung cancers attributable to six years of exposure to asbestos in schools. Without exposure 32 000 subjects are expected to die from lung cancer from a population of one million. Among a similar cohort exposed to 0001 f/ml ofmixed fibres, 0 6 additional lung cancers are expected. The relative risk is therefore 1 000019. This is an expected relative risk obtained from mathematical extrapolations. A prospective study aimed at showing with facts that actually the observed risk is as high as 1 -000019 would require' two groups of 2 654 billion subjects (a = , = 0 05). Therefore such risks can only be evaluated by mathematical modelling and the use of sensitivity analysis is crucial. Shifting to "low" exposures at work a well designed cohort study, based on data from the same paper of Hughes and Weill, would require two groups of 5 000 subjects to show that the relative risk of lung cancer is 1 05 for subjects exposed during 20 years at 0-5 f/ml, as would be expected from model projections. This implies collaborative works or meta-analysis.
Surprisingly some individual studies based on small numbers of subjects have led to figures of increased risk of cancer in subjects exposed to very low doses of asbestos. The two rational explanations are that the actual risk at such low doses is much higher than the one predicted from extrapolation models, or that the studies were wrong because of a bias in the measurement of the dose, or of the effect. Also, there could be a publication bias-that is, among numerous small studies, only those that led to "significant" results were published.
To obtain answers on risk assessment for exposures at work, it may be tempting to pool the results obtained from individual surveys to obtain sufficient statistical power. This is usually referred to as a meta-analytic approach. Only one meta-analysis study had been done in the field of epidemiology of gastrointestinal cancer associated with asbestos,4' whereas this approach has been used in several instances in studies of passive smoking in which one is faced with comparable methodological difficulties of risk assessment. Use of meta-analysis implies fulfilling two conditions, one avoiding publication bias by establishing a registry of all studies, two assessing that each of the constituting studies meet given quality criteria. Meta-analysis on its own may well not bring new knowledge but the procedure for systematically and critically examining studies according to a set of well defined rules might be valuable and informative, as noted by Dr Saracci.
As The future demands closer interaction between laboratories with increasing uniformity and attention to the measurement and reporting of parameters designed to improve the knowledge of exposure and of mechanisms of disease causation and risk prediction.
CONCERNING THE EPIDEMIOLOGICAL METHODOLOGY
Because of the necessity of huge sample sizes, multicentre studies are essential to provide valid information on the possible effects in humans of low level exposures to natural and man made fibres. The development of alternative biostatistical methods and the improvement of the quality of existing mathematical and statistical approaches must be encouraged. 
